Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilastine vs cetirizine vs placebo in seasonal allergic rhinitis
2004-004586-14Phase 3Completed
- Sponsor
- Faes Farma
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bilastine in seasonal allergic rhinitis (SAR) (3 arms), sponsored by Faes Farma. Primary endpoint: Area under the curve of total symptom score (TSS) over 14 days. Started Apr 2005; status: completed.
02
Drugs
bilastine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2004-004586-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004586-14.